These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28012775)

  • 1. Comparison of functional assays used in the clinical development of a placental malaria vaccine.
    Pehrson C; Heno KK; Adams Y; Resende M; Mathiesen L; Soegaard M; de Jongh WA; Theander TG; Salanti A; Nielsen MA
    Vaccine; 2017 Jan; 35(4):610-618. PubMed ID: 28012775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
    Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
    J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel adenovirus encoded virus-like particles displaying the placental malaria associated VAR2CSA antigen.
    Andersson AC; Resende M; Salanti A; Nielsen MA; Holst PJ
    Vaccine; 2017 Feb; 35(8):1140-1147. PubMed ID: 28131394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating antibody functional activity and strain-specificity of vaccine candidates for malaria in pregnancy using in vitro phagocytosis assays.
    Hommel M; Chan JA; Umbers AJ; Langer C; Rogerson SJ; Smith JD; Beeson JG
    Parasit Vectors; 2018 Jan; 11(1):69. PubMed ID: 29378634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of adjuvants on the immune response induced by a DBL4ɛ-ID4 VAR2CSA based Plasmodium falciparum vaccine against placental malaria.
    Pinto VV; Salanti A; Joergensen LM; Dahlbäck M; Resende M; Ditlev SB; Agger EM; Arnot DE; Theander TG; Nielsen MA
    Vaccine; 2012 Jan; 30(3):572-9. PubMed ID: 22122859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of VAR2CSA-deficient Plasmodium falciparum-infected erythrocytes selected for adhesion to the BeWo placental cell line.
    Yosaatmadja F; Andrews KT; Duffy MF; Brown GV; Beeson JG; Rogerson SJ
    Malar J; 2008 Mar; 7():51. PubMed ID: 18364051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential adhesion-inhibitory patterns of antibodies raised against two major variants of the NTS-DBL2X region of VAR2CSA.
    Doritchamou J; Bigey P; Nielsen MA; Gnidehou S; Ezinmegnon S; Burgain A; Massougbodji A; Deloron P; Salanti A; Ndam NT
    Vaccine; 2013 Sep; 31(41):4516-22. PubMed ID: 23933341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
    Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
    Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
    Elife; 2022 Feb; 11():. PubMed ID: 35103596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NTS-DBL2X region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin sulfate A.
    Bigey P; Gnidehou S; Doritchamou J; Quiviger M; Viwami F; Couturier A; Salanti A; Nielsen MA; Scherman D; Deloron P; Tuikue Ndam N
    J Infect Dis; 2011 Oct; 204(7):1125-33. PubMed ID: 21881129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
    Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
    PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
    Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
    Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesion of Plasmodium falciparum infected erythrocytes in ex vivo perfused placental tissue: a novel model of placental malaria.
    Pehrson C; Mathiesen L; Heno KK; Salanti A; Resende M; Dzikowski R; Damm P; Hansson SR; King CL; Schneider H; Wang CW; Lavstsen T; Theander TG; Knudsen LE; Nielsen MA
    Malar J; 2016 May; 15(1):292. PubMed ID: 27230523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
    Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
    Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
    Nielsen MA; Resende M; de Jongh WA; Ditlev SB; Mordmüller B; Houard S; Ndam NT; Agerbæk MØ; Hamborg M; Massougbodji A; Issifou S; Strøbæk A; Poulsen L; Leroy O; Kremsner PG; Chippaux JP; Luty AJ; Deloron P; Theander TG; Dyring C; Salanti A
    PLoS One; 2015; 10(9):e0135406. PubMed ID: 26327283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
    Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
    Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
    Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.